FDA DEVICE FACTS
VitaSmart Hypothermic Oxygenated Perfusion System
Bridge TO Life, Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The VitaSmart Hypothermic Oxygenated Perfusion (HOPE) System is intended to be used for hypothermic oxygenated perfusion of donor livers, after a period of static cold storage (SCS), for eventual transplantation into a recipient. The VitaSmart HOPE System is not intended to be used while the organ is in transport. The device is indicated for use with Donation after Brain Death (DBD) donor livers ≤ 65 years old; or Donation after Circulatory Death (DCD) donor livers ≤ 55 years old and with ≤ 18 minutes of functional warm ischemic time with macrosteatosis ≤ 10%. The VitaSmart HOPE System is intended for use by qualified healthcare professionals trained in the use of the VitaSmart HOPE System.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。